220 related articles for article (PubMed ID: 22670138)
1. Pitt-Hopkins Syndrome.
Peippo M; Ignatius J
Mol Syndromol; 2012 Apr; 2(3-5):171-180. PubMed ID: 22670138
[TBL] [Abstract][Full Text] [Related]
2. The Pitt-Hopkins syndrome: report of 16 new patients and clinical diagnostic criteria.
Marangi G; Ricciardi S; Orteschi D; Lattante S; Murdolo M; Dallapiccola B; Biscione C; Lecce R; Chiurazzi P; Romano C; Greco D; Pettinato R; Sorge G; Pantaleoni C; Alfei E; Toldo I; Magnani C; Bonanni P; Martinez F; Serra G; Battaglia D; Lettori D; Vasco G; Baroncini A; Daolio C; Zollino M
Am J Med Genet A; 2011 Jul; 155A(7):1536-45. PubMed ID: 21671391
[TBL] [Abstract][Full Text] [Related]
3. Impairment of different protein domains causes variable clinical presentation within Pitt-Hopkins syndrome and suggests intragenic molecular syndromology of TCF4.
Bedeschi MF; Marangi G; Calvello MR; Ricciardi S; Leone FPC; Baccarin M; Guerneri S; Orteschi D; Murdolo M; Lattante S; Frangella S; Keena B; Harr MH; Zackai E; Zollino M
Eur J Med Genet; 2017 Nov; 60(11):565-571. PubMed ID: 28807867
[TBL] [Abstract][Full Text] [Related]
4. Novel comprehensive diagnostic strategy in Pitt-Hopkins syndrome: clinical score and further delineation of the TCF4 mutational spectrum.
Whalen S; Héron D; Gaillon T; Moldovan O; Rossi M; Devillard F; Giuliano F; Soares G; Mathieu-Dramard M; Afenjar A; Charles P; Mignot C; Burglen L; Van Maldergem L; Piard J; Aftimos S; Mancini G; Dias P; Philip N; Goldenberg A; Le Merrer M; Rio M; Josifova D; Van Hagen JM; Lacombe D; Edery P; Dupuis-Girod S; Putoux A; Sanlaville D; Fischer R; Drévillon L; Briand-Suleau A; Metay C; Goossens M; Amiel J; Jacquette A; Giurgea I
Hum Mutat; 2012 Jan; 33(1):64-72. PubMed ID: 22045651
[TBL] [Abstract][Full Text] [Related]
5. Various haploinsufficiency mechanisms in Pitt-Hopkins syndrome.
Sparber P; Filatova A; Anisimova I; Markova T; Voinova V; Chuhrova A; Tabakov V; Skoblov M
Eur J Med Genet; 2020 Dec; 63(12):104088. PubMed ID: 33069932
[TBL] [Abstract][Full Text] [Related]
6. Pitt-Hopkins syndrome-associated mutations in TCF4 lead to variable impairment of the transcription factor function ranging from hypomorphic to dominant-negative effects.
Sepp M; Pruunsild P; Timmusk T
Hum Mol Genet; 2012 Jul; 21(13):2873-88. PubMed ID: 22460224
[TBL] [Abstract][Full Text] [Related]
7. Mosaic 18q21.2 deletions including the TCF4 gene: a clinical report.
Rossi M; Labalme A; Cordier MP; Till M; Blanchard G; Dubois R; Guibaud L; Heissat S; Javouhey E; Lachaux A; Mure PY; Ville D; Edery P; Sanlaville D
Am J Med Genet A; 2012 Dec; 158A(12):3174-81. PubMed ID: 23165966
[TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype analysis of TCF4 mutations causing Pitt-Hopkins syndrome shows increased seizure activity with missense mutations.
Rosenfeld JA; Leppig K; Ballif BC; Thiese H; Erdie-Lalena C; Bawle E; Sastry S; Spence JE; Bandholz A; Surti U; Zonana J; Keller K; Meschino W; Bejjani BA; Torchia BS; Shaffer LG
Genet Med; 2009 Nov; 11(11):797-805. PubMed ID: 19938247
[TBL] [Abstract][Full Text] [Related]
9. The recurrent TCF4 missense variant p.(Arg389Cys) causes a neurodevelopmental disorder overlapping with but not typical for Pitt-Hopkins syndrome.
Popp B; Bienvenu T; Giurgea I; Metreau J; Kraus C; Reis A; Fischer J; Bralo MP; Tenorio-Castaño J; Lapunzina P; Almoguera B; Lopez-Grondona F; Sticht H; Zweier C
Clin Genet; 2022 Dec; 102(6):517-523. PubMed ID: 35908153
[TBL] [Abstract][Full Text] [Related]
10. A case of Pitt-hopkins Syndrome with de novo mutation in TCF4: Clinical features and treatment for epilepsy.
Liu Y; Guo Y; Liu P; Li F; Yang C; Song J; Hu J; Xin D; Chen Z
Int J Dev Neurosci; 2018 Jun; 67():51-54. PubMed ID: 29604340
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of TCF4 missense mutations that cause Pitt-Hopkins syndrome.
Forrest M; Chapman RM; Doyle AM; Tinsley CL; Waite A; Blake DJ
Hum Mutat; 2012 Dec; 33(12):1676-86. PubMed ID: 22777675
[TBL] [Abstract][Full Text] [Related]
12. Proposal of a clinical score for the molecular test for Pitt-Hopkins syndrome.
Marangi G; Ricciardi S; Orteschi D; Tenconi R; Monica MD; Scarano G; Battaglia D; Lettori D; Vasco G; Zollino M
Am J Med Genet A; 2012 Jul; 158A(7):1604-11. PubMed ID: 22678594
[TBL] [Abstract][Full Text] [Related]
13. A typical variant in TCF4 exon 18 is not associated with Pitt-Hopkins syndrome but with a familial case of mild and nonspecific neurodevelopmental disorder.
Aldeeri AA; Abu-El-Haija A
Am J Med Genet A; 2023 Apr; 191(4):1070-1076. PubMed ID: 36574749
[TBL] [Abstract][Full Text] [Related]
14. Common Pathophysiology in Multiple Mouse Models of Pitt-Hopkins Syndrome.
Thaxton C; Kloth AD; Clark EP; Moy SS; Chitwood RA; Philpot BD
J Neurosci; 2018 Jan; 38(4):918-936. PubMed ID: 29222403
[TBL] [Abstract][Full Text] [Related]
15. [Pitt-Hopkins syndrome - own experience on the base of two case reports and literature review with special emphasis on differential diagnosis].
Stembalska A; Smigiel R
Dev Period Med; 2014; 18(2):169-75. PubMed ID: 25182255
[TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanisms of Transcription Factor 4 in Pitt Hopkins Syndrome.
Rannals MD; Maher BJ
Curr Genet Med Rep; 2017 Mar; 5(1):1-7. PubMed ID: 30775158
[TBL] [Abstract][Full Text] [Related]
17. Pitt-Hopkins Syndrome and Differential Diagnosis: A Molecular and Clinical Challenge.
Marangi G; Zollino M
J Pediatr Genet; 2015 Sep; 4(3):168-76. PubMed ID: 27617128
[TBL] [Abstract][Full Text] [Related]
18. Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1.
Gregor A; Albrecht B; Bader I; Bijlsma EK; Ekici AB; Engels H; Hackmann K; Horn D; Hoyer J; Klapecki J; Kohlhase J; Maystadt I; Nagl S; Prott E; Tinschert S; Ullmann R; Wohlleber E; Woods G; Reis A; Rauch A; Zweier C
BMC Med Genet; 2011 Aug; 12():106. PubMed ID: 21827697
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
